Dale Nordenberg

Executive Director and CEO
Medical Device Innovation, Safety and Security Consortium/Novasano
Dr. Nordenberg is CEO of Novasano Health and Science, a company that delivers information technology services and products to accelerate innovation in healthcare and life sciences. He has extensive experience in healthcare strategy and operations, health information technology, FDA regulated industries, research network development, public-private partnership development, and emergency preparedness. Dr. Nordenberg is Executive Director for the Medical Device Innovation, Safety and Security Consortium (MDISS), a public-private partnership that works with device manufacturers, healthcare systems, government agencies, and other stakeholders to improve the security and safety of medical devices and biomedical device networks. He serves on the Brookings Institute Medical Device Post Market Surveillance System Planning Board and recently coordinated a National Academy of Sciences Innovation Policy Forum briefing on medical device innovation. Dr. Nordenberg was a managing director in the health care practice of PricewaterhouseCoopers. From 2002 through 2007, he was the Chief Information Officer and Associate Director, National Center for Infectious Diseases and was detailed to the Office of the National Coordinator for Health Information Technology. He was a member of the Science and Technology Review Subcommittee of the Science Advisory Board of the FDA, 2007 and 2009. Prior to CDC, Dr. Nordenberg was a founding executive of a company that launched VeriSign affiliates in Latin America and Asia; faculty in the Emory School of Medicine where he founded and directed the Office of Medical Informatics for the Emory University Children's Center. Dr. Nordenberg is a pediatrician, medical epidemiologist and medical informacist. He completed a BS in Microbiology from the University of Michigan, medical degree from Northwestern University, pediatrics residency at McGill University, and fellowship in epidemiology in the Epidemic Intelligence Services Program at the CDC.